PPP1R3C and breast carcinoma: While high AhRR expression significantly correlates with worse overall patient survival in different cancers (breast carcinoma, chromophobe renal cell carcinoma, lower grade glioma, sarcomas, and nevi and uveal melanomas, see Figure S2), PPP1R3C expression showed a negative or positive prognostic role, based on the cancer type (Figure S3).